New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
07:08 EDTAKRXAkorn price target raised to $33 from $30 at Piper Jaffray
Piper Jaffray raised its price target for Akorn shares to $33 to reflect the company's acquisition of VersaPharm. Piper believes Akorn has one of the most attractive long-term growth profiles in the broader specialty pharma space and it keeps an Overweight rating on the stock.
News For AKRX From The Last 14 Days
Check below for free stories on AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
09:28 EDTAKRXAkorn recent pullback a buying opportunity, says Craig-Hallum
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use